Terms: = Colorectal cancer AND SUZ12, CHET9, 23512, ENSG00000178691, Q15022, KIAA0160, JJAZ1 AND Prognosis
4 results:
1. Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer.
Liao MY; Kuo MY; Lu TY; Wang YP; Wu HC
Int J Oncol; 2015 Apr; 46(4):1788-800. PubMed ID: 25652097
[TBL] [Abstract] [Full Text] [Related]
2. Expression and clinicopathological significance of EED, suz12 and EZH2 mRNA in colorectal cancer.
Liu YL; Gao X; Jiang Y; Zhang G; Sun ZC; Cui BB; Yang YM
J Cancer Res Clin Oncol; 2015 Apr; 141(4):661-9. PubMed ID: 25326896
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of polycomb proteins EZH2, BMI1 and suz12 and histone modification H3K27me3 in colorectal cancer.
Benard A; Goossens-Beumer IJ; van Hoesel AQ; Horati H; Putter H; Zeestraten EC; van de Velde CJ; Kuppen PJ
PLoS One; 2014; 9(9):e108265. PubMed ID: 25243792
[TBL] [Abstract] [Full Text] [Related]
4. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers.
Kogo R; Shimamura T; Mimori K; Kawahara K; Imoto S; Sudo T; Tanaka F; Shibata K; Suzuki A; Komune S; Miyano S; Mori M
Cancer Res; 2011 Oct; 71(20):6320-6. PubMed ID: 21862635
[TBL] [Abstract] [Full Text] [Related]
